STOCK INCENTIVE PLAN	3 Months Ended
Mar. 31, 2024
STOCK INCENTIVE PLAN
STOCK INCENTIVE PLAN	NOTE 10: STOCK INCENTIVE PLAN On May 29, 2015 the Company adopted its 2015 Stock Incentive Plan. Under the Plan the Company may issue up to 10,000,000 S-8 shares to officers, employees, directors or consultants for services rendered to the Company or its affiliates or to incentivize such parties to continue to render services. S-8 shares are registered immediately upon the filing of the Plan and are unrestricted shares that are free-trading upon issuance. On May 20, 2021 the board consent increased the issue up to 20,000,000 shares. Subsequently that amount was raised to 40,000,000 shares As of March 31, 2024 and December 31, 2023, there were 25,881,671 and 9,806,000 shares available for issuance under the Plan. On May 9, 2023 2,000,000 in options were issued with a strike price of 0.21 per share vesting over 6 months. On September 1, 2023, 1,000,000 in options were issued with a strike price of 0.023 per share vesting over 3 months. For the three months ended March 31, 2024 and March 31, 2023, the Company recorded compensation expense of $9,613 and $103,822 respectively.

STOCK INCENTIVE PLAN

3 Months Ended

Mar. 31, 2024

NOTE 10: STOCK INCENTIVE PLAN

On May 29, 2015 the Company adopted its 2015 Stock Incentive Plan. Under the Plan the Company may issue up to 10,000,000 S-8 shares to officers, employees, directors or consultants for services rendered to the Company or its affiliates or to incentivize such parties to continue to render services. S-8 shares are registered immediately upon the filing of the Plan and are unrestricted shares that are free-trading upon issuance. On May 20, 2021 the board consent increased the issue up to 20,000,000 shares. Subsequently that amount was raised to 40,000,000 shares As of March 31, 2024 and December 31, 2023, there were 25,881,671 and 9,806,000 shares available for issuance under the Plan.

On May 9, 2023 2,000,000 in options were issued with a strike price of 0.21 per share vesting over 6 months.

On September 1, 2023, 1,000,000 in options were issued with a strike price of 0.023 per share vesting over 3 months.

For the three months ended March 31, 2024 and March 31, 2023, the Company recorded compensation expense of $9,613 and $103,822 respectively.

AXIM BIOTECHNOLOGIES, INC. 10-Q/A